activins has been researched along with oxidopamine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amit, T; Bar-Am, O; Blumenfeld, Z; Kupershmidt, L; Youdim, MB | 1 |
| Li, KM; Rentsch, P; Stayte, S; Vissel, B | 1 |
| Morris, GP; Rentsch, P; Stayte, S; Vissel, B | 1 |
3 other study(ies) available for activins and oxidopamine
| Article | Year |
|---|---|
The neuroprotective effect of Activin A and B: implication for neurodegenerative diseases.
Topics: Activins; Animals; Apoptosis; Apoptosis Regulatory Proteins; Brain; Cell Line, Tumor; Cell Survival; Culture Media, Serum-Free; Histones; Humans; Molsidomine; Nerve Degeneration; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Oxidative Stress; Oxidopamine; PC12 Cells; Poly(ADP-ribose) Polymerases; Rats; Transfection; Tyrosine 3-Monooxygenase | 2007 |
Activin A protects midbrain neurons in the 6-hydroxydopamine mouse model of Parkinson's disease.
Topics: Activins; Animals; Cell Survival; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopaminergic Neurons; Gene Expression Regulation; Injections, Intraventricular; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Oxidopamine; Parkinson Disease, Secondary; Pars Compacta; Signal Transduction; Stereotaxic Techniques | 2015 |
Time dependent degeneration of the nigrostriatal tract in mice with 6-OHDA lesioned medial forebrain bundle and the effect of activin A on L-Dopa induced dyskinesia.
Topics: Activins; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antiparkinson Agents; Disease Progression; Dyskinesia, Drug-Induced; Levodopa; Male; Medial Forebrain Bundle; Mice, Inbred C57BL; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Oxidopamine; Parkinsonian Disorders; Random Allocation; Treatment Failure | 2019 |